Neonatal hypoxia and pulmonary vasospasm: response to tolazoline. 1976

B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman

Forty-six neonates with hypoxemia were treated with tolazoline, a pulmonary vasodilator, within the first two days of life. Eight of ten (80%) infants without apparent lung disease responded with a mean increase in PaO2 of 116 torr within one hour of beginning tolazoline infusions. One of the responding infants and two nonresponders died. Thirty-six additional infants with a variety of pulmonary disorders had severe hypoxemia which was refractory to mechanical ventilation. Twenty-one (58%) responded with a mean increase in PaO2 of 130 torr within one hour after beginning tolazoline and 13 (62%) of these survived. Fifteen patients had little or no improvement in PaO2 following tolazoline and only three (20%) of these infants survived. Responders could not be distinguished from nonresponders by clinical or laboratory features prior to therapy with tolazoline. Fourteen infants experienced complications possibly related to tolazoline.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008297 Male Males
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D005260 Female Females
D006471 Gastrointestinal Hemorrhage Bleeding in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Hematochezia,Hemorrhage, Gastrointestinal,Gastrointestinal Hemorrhages,Hematochezias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000860 Hypoxia Sub-optimal OXYGEN levels in the ambient air of living organisms. Anoxia,Oxygen Deficiency,Anoxemia,Deficiency, Oxygen,Hypoxemia,Deficiencies, Oxygen,Oxygen Deficiencies
D014043 Tolazoline A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn. Benzalolin,Divascol,Pridazole,Priscol,Priscoline,Tolazoline Hydrochloride,Tolazoline Monohydrochloride

Related Publications

B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
January 1980, Acta paediatrica Scandinavica,
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
March 1986, Pediatrics,
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
January 1984, Pediatric pharmacology (New York, N.Y.),
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
September 1993, Pediatrics,
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
January 1972, Journal of pediatric surgery,
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
January 1985, Pediatric pharmacology (New York, N.Y.),
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
December 1996, Acta paediatrica (Oslo, Norway : 1992),
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
October 1979, The Journal of pediatrics,
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
March 1967, International journal of biometeorology,
B W Goetzman, and P Sunshine, and J D Johnson, and R P Wennberg, and A Hackel, and D F Merten, and A L Bartoletti, and N H Silverman
August 1979, Pediatric research,
Copied contents to your clipboard!